What is the long-term survival benefit of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease?
A study conducted by Jones et al. (1996) evaluated the long-term survival benefits of coronary artery bypass grafting (CABG) and percutaneous transluminal angioplasty (PTCA) in patients with coronary artery disease. The results of the study showed that CABG provided a statistically significant survival benefit compared to PTCA after 12 years of follow-up. Additionally, the study conducted by Varnauskas (1988) showed that CABG provided a significant long-term survival benefit compared to medical therapy after 12 years of follow-up. Finally, a study conducted by Smith et al. (2006) showed that CABG provided a greater longevity benefit compared to PTCA in patients with multivessel coronary artery disease and high-risk features.